Share on LinkedInShare on LinkedIn

ARTICLE · 08 APRIL 2020

SEC Issues New COVID-19 Disclosure Guidance

A&O Shearman
A&O Shearman
Contributor

A&O Shearman

Introducing A&O Shearman Unparalleled global depth for a changing world. Today more than ever,...

View firm profile
Explore more from A&O Shearman

This client alert supplements and updates our client alert issued on March 16, 2020, which discusses disclosure and capital markets considerations for U.S. listed public companies.

United StatesCoronavirus (COVID-19)

As part of its response to the effects and economic disruption that the novel coronavirus disease 2019 ("COVID-19") is causing to the worldwide economy, on March 25, 2020, the Division of Corporation Finance of the U.S. Securities and Exchange Commission ("SEC") issued additional guidance regarding public company disclosure requirements with respect to COVID-19.1

This client alert supplements and updates our client alert issued on March 16, 2020, which discusses disclosure and capital markets considerations for U.S. listed public companies.2

COVID-19 Disclosure Considerations 

The guidance reminds companies that, while it is difficult to predict with precision the effects of COVID-19 on a company, management's views on COVID-19's effects and future impact on the company can be material to investment and voting decisions.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from